LIEN
Price
$11.01
Change
+$0.11 (+1.01%)
Updated
Aug 29 closing price
Capitalization
251.25M
68 days until earnings call
TXMD
Price
$1.11
Change
-$0.01 (-0.89%)
Updated
Aug 29 closing price
Capitalization
12.85M
79 days until earnings call
Interact to see
Advertisement

LIEN vs TXMD

Header iconLIEN vs TXMD Comparison
Open Charts LIEN vs TXMDBanner chart's image
Chicago Atlantic BDC
Price$11.01
Change+$0.11 (+1.01%)
Volume$96.48K
Capitalization251.25M
TherapeuticsMD
Price$1.11
Change-$0.01 (-0.89%)
Volume$21.23K
Capitalization12.85M
LIEN vs TXMD Comparison Chart in %
Loading...
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LIEN vs. TXMD commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIEN is a StrongBuy and TXMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (LIEN: $11.01 vs. TXMD: $1.11)
Brand notoriety: LIEN and TXMD are both not notable
LIEN represents the Investment Managers, while TXMD is part of the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LIEN: 298% vs. TXMD: 94%
Market capitalization -- LIEN: $251.25M vs. TXMD: $12.85M
LIEN [@Investment Managers] is valued at $251.25M. TXMD’s [@Pharmaceuticals: Generic] market capitalization is $12.85M. The market cap for tickers in the [@Investment Managers] industry ranges from $174.54B to $0. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Investment Managers] industry is $7.62B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIEN’s FA Score shows that 1 FA rating(s) are green whileTXMD’s FA Score has 0 green FA rating(s).

  • LIEN’s FA Score: 1 green, 4 red.
  • TXMD’s FA Score: 0 green, 5 red.
According to our system of comparison, LIEN is a better buy in the long-term than TXMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIEN’s TA Score shows that 4 TA indicator(s) are bullish while TXMD’s TA Score has 2 bullish TA indicator(s).

  • LIEN’s TA Score: 4 bullish, 5 bearish.
  • TXMD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, LIEN is a better buy in the short-term than TXMD.

Price Growth

LIEN (@Investment Managers) experienced а +1.29% price change this week, while TXMD (@Pharmaceuticals: Generic) price change was +0.92% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was +1.19%. For the same industry, the average monthly price growth was +2.93%, and the average quarterly price growth was +17.50%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.55%. For the same industry, the average monthly price growth was +67.47%, and the average quarterly price growth was +80.21%.

Reported Earning Dates

LIEN is expected to report earnings on Nov 06, 2025.

TXMD is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Investment Managers (+1.19% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Pharmaceuticals: Generic (+1.55% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LIEN($251M) has a higher market cap than TXMD($12.8M). TXMD YTD gains are higher at: 29.070 vs. LIEN (-3.775). TXMD has more cash in the bank: 6.07M vs. LIEN (5.4K). LIEN has less debt than TXMD: LIEN (5M) vs TXMD (6.6M). LIEN has higher revenues than TXMD: LIEN (31.4M) vs TXMD (2.56M).
LIENTXMDLIEN / TXMD
Capitalization251M12.8M1,961%
EBITDAN/A-1.37M-
Gain YTD-3.77529.070-13%
P/E Ratio8.16N/A-
Revenue31.4M2.56M1,227%
Total Cash5.4K6.07M0%
Total Debt5M6.6M76%
FUNDAMENTALS RATINGS
TXMD: Fundamental Ratings
TXMD
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LIENTXMD
RSI
ODDS (%)
Bearish Trend 1 day ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
50%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 12 days ago
61%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
56%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LIEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TXMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CGTRF0.02N/A
+30.87%
GT RESOURCES INC.
SXGCF4.270.01
+0.23%
Southern Cross Gold Consolidated Ltd.
VLPNF21.93N/A
N/A
Voestalpine AG
NTBP1250.00N/A
N/A
New Tripoli Bancorp, Inc.
ASAZY17.60-0.06
-0.34%
Assa Abloy AB

LIEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIEN has been loosely correlated with TXMD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LIEN jumps, then TXMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIEN
1D Price
Change %
LIEN100%
+1.01%
TXMD - LIEN
36%
Loosely correlated
-0.89%
AVDL - LIEN
24%
Poorly correlated
+0.96%
SHPH - LIEN
21%
Poorly correlated
-0.60%
OXLCP - LIEN
12%
Poorly correlated
+0.32%
BAM - LIEN
11%
Poorly correlated
-0.25%
More

TXMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TXMD has been loosely correlated with LIEN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if TXMD jumps, then LIEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXMD
1D Price
Change %
TXMD100%
-0.89%
LIEN - TXMD
36%
Loosely correlated
+1.01%
DRRX - TXMD
32%
Poorly correlated
-1.03%
ASRT - TXMD
27%
Poorly correlated
+2.97%
TLPH - TXMD
26%
Poorly correlated
-0.86%
TLRY - TXMD
25%
Poorly correlated
-6.12%
More